
Dimitrios (Dimitri) Makrakis
@dmakrakismd
MD, PGY-3 @jacobihosp @einsteinmed - GU Onc Research Fellow @UoWashington from @UOC_gr ๐ฌ๐ท๐บ๐ฒ
ID: 1302006230626512896
https://scholar.google.com/citations?user=NLuKUbsAAAAJ&hl=en 04-09-2020 22:11:10
298 Tweet
586 Followers
551 Following


So proud of amazing mentee Stepan M. Esagian, MD with phenomenal match MD Anderson Cancer Center he will work with stellar colleagues Pavlos Msaouel (who has mentored him exceptionally) Omar Alhalabi, MD Nazli Dizman Eric Jonasch Matt Campbell MD, MS Andy Hahn et al.! Dimitrios (Dimitri) Makrakis IMG Oncologists OncoAlert

Out now: ICI efficacy in FGFR, MTAP, ERBB2 alterations ๐งฌ in aUC. Very happy for more research with this fantastic team Rafee Talukder Dimitra R. Bakaloudi MD, MS, MPA Ali Khaki Neeraj Agarwal, MD, FASCO Vadim Koshkin MD @LDiamantMD92 Pedro C Barata, MD MSc FACP Shilpa Gupta Petros Grivas and more!

Marc-Olivier Timsit, MD, PhD ๐๏ธ Petros Grivas Cleveland Clinic Karima Oualla, MD,MSc Nawfel MELLAS Agree ๐ฏAmazing discussion by Petros Grivas discussing nuances of IO-based perioperative tx in MIBC. Is pCR a relevant endpoint? Need to tease out neoadjuvant vs adjuvant contribution of IO instead of blanket approach. Deep dive into NIAGARA trial which he discussed at ESMO - Eur. Oncology


Truly honored to receive this recognition from Conquer Cancer, the ASCO Foundation! Excited to present our findings on cytoreductive nephrectomy utilization trends and disparities at ASCO #GU25. Grateful to my mentors and collaborators Pavlos Msaouel Dimitrios (Dimitri) Makrakis


Excited to see our work with โญ๏ธStepan M. Esagian, MD Pavlos Msaouel being featured in #ascoGU25 among many others! Interesting trend of declining CN rates even before CARMENA. Petros Grivas Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO Ali Khaki Dan George Andrew Gutwein MD Jacobi Internal Medicine Chiefs

1/5 Sharing our Clinical Cancer Research work establishing serum CA-125 as a biomarker for #RenalMedullaryCarcinoma. This is now the first cancer-associated blood biomarker to become standard of care and used globally for a #kidneycancer : aacrjournals.org/clincancerres/โฆ The V Foundation for Cancer Research Chris Johnson Foundation Inc.


Honored to serve in my new role as co-chair of ECOG-ACRIN Cancer Research Group GU committee working with amazing Naomi Haas & stellar colleagues nationwide! Have been in ECOG-ACRIN Cancer Research Group for 11 years: huge progress, many opportunities ahead! MJ Fred Hutchinson Cancer Center Dr. Tom Lynch Nicole D. Fleming MD OncoAlert

Join our GU dream team Fred Hutch Cancer Center UW Medicine dedicated to exceptional patient care, innovative research, education, outreach, career growth! We have 2 open positions, links below: apply.interfolio.com/165668 apply.interfolio.com/158802 Nicole D. Fleming MD Hsieh Lab Sarah P. Psutka MD MS Daniel Lin

Investigating PARP expression as a biomarker for targeted therapy in #ProstateCancer. Emmanuel Antonarakis Masonic Cancer Center, University of Minnesota sits down with Neeraj Agarwal Huntsman Cancer Institute to unpack how PARP1 expression could redefine PARP inhibitor use in prostate cancer. In BRCA2+ patients, high PARP1 = 100%



Such a well deserved recognition for Petros Grivas who has been incredibly dedicated to patient care and research! Fantastic role model! Mentees are very grateful Stepan M. Esagian, MD Phaedon Zavras Dimitra R. Bakaloudi MD, MS, MPA Panos Zoubourlis

Fantastic and informative session, thank you Petros Grivas Enrique Grande and of course Oncology Brothers !!

To all IMGs out there, the path is long but very much possible and rewarding. Many will say you canโt do it, weโre here say you can! Nicole Mott CU Department of Surgery AJS Student and Resident Scholar (STARS) Committee IMG_stories Project IMG โข Project IMG Network

So honored to receive this prestigious award by ECOG-ACRIN Cancer Research Group kudos to all investigators/staff who work hard to conduct trials globally! PrECOG Naomi Haas MJ Jean Hoffman-Censits Dr. Tom Lynch Nicole D. Fleming MD Amer Zeidan MBBS,MHS โุนุงู ุฑ ุฒูุฏุงู Manmeet Ahluwalia, MD, MBA, FASCO Shilpa Gupta OncoAlert Tian Zhang, MD, MHS


New editorโs choice by Malte Rieken: Deferred cytoreductive nephrectomy is superior to upfront nephrectomy. doi.org/10.1016/j.euf.โฆ Stepan M. Esagian, MD, Jose Karam, Pavlos Msaouel Dimitrios (Dimitri) Makrakis


ctDNA in #BladderCancer: Prognostic value and ongoing clinical trials. Jonathan Rosenberg MD Memorial Sloan Kettering Cancer Center & Petros Grivas Fred Hutch Cancer Center join Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center to discuss on UroToday. ๐งฌ ctDNA in bladder cancer: promising but not practice-changingโyet. They explain that


Join ๐๐ก๐๐ง๐๐ฅ๐๐ซ ๐๐๐ซ๐ค ๐๐ ๐ ๐๐๐ & me on Dec 13 in Seattle for a fantastic Master Lectures series with stellar speakers, interactions, fun! Register below: masterlectureseries.com/registration-mโฆ Pavlos Msaouel Mazyar Shadman, MD MPH Rahul Banerjee, MD, FACP Dimitra R. Bakaloudi MD, MS, MPA Dimitrios (Dimitri) Makrakis Hsieh Lab Danai Dima Fred Hutch Cancer Center Omar Mian
